Search - tctmd.com

Displaying 61 - 80 of 93

Sort: Relevancy | Date

Presentation TCT 2014

Pro: Follow the Data - and Save the Money!

Presenter: Adrian P. Banning, Rod H. Stables

September 16, 2014

Presentation TCT 2014

Definitely To Prevent Stent Thrombosis and MI!

Presenter: Gregg W. Stone

September 15, 2014

Presentation TCT 2014

Definitely Not An Expensive Way to Increase Bleeding Without Much Benefit!

Presenter: Nick Curzen

September 15, 2014

Presentation TCT 2014

The Case for Selective Use of Prasugrel and Ticagrelor in PCI Patients with Stable CAD

Presenter: Robert A. Harrington, Ajay J. Kirtane, Thomas D. Stuckey, Matthew J. Price

September 14, 2014

Presentation TCT 2014

Time to Move to 3-6 Months Even in ACS!

Presenter: Marco Valgimigli

September 14, 2014

Presentation TCT 2014

Definitely Not the Data are Clear!

Presenter: Germano Di Sciascio

September 14, 2014

Presentation TCT 2014

Definitely the Data are Clear!

Presenter: E. Magnus Ohman

September 14, 2014

Presentation TCT 2014

The Data Strongly Support Heparin!

Presenter: Rod H. Stables

September 14, 2014

Presentation TCT 2014

State of the (Drug-Eluting) Stent: World-Wide Usage, New Perspectives in Stable CAD, and Remaining Challenges

Presenter: Donald Cutlip, Manel Sabate, Elvin Kedhi

September 14, 2014

Presentation TCT 2014

Position Statement: Heparin Will Once Again Become the Anticoagulant of Choice for PCI in Stable and Unstable Coronary Syndromes

Presenter: Kishore J. Harjai, Michael S. Lee

September 14, 2014

Presentation TCT 2014

Case #3. Multivessel Disease in a Stable CAD Patient

Presenter: Eric A. Cohen, Dean J. Kereiakes, Samer Mansour

September 14, 2014

Presentation

Impact of the System and Physician Factors on the Detection of Obstructive CAD with Diagnostic Angiography in Stable Ischemic Heart Disease

Presenter: Harindra C. Wijeysundera

September 11, 2014

Presentation

Prevalence of Anginal Symptoms and Myocardial Ischemia and Their Effect on Clinical Outcomes in Outpatients With Stable CAD

Presenter: Philippe Gabriel Steg

August 15, 2014

Presentation

Rate of PCI for the Management of ACS and Stable CAD in the United States (2007-2011)

Presenter: Luke K. Kim

July 24, 2014

Presentation

DAPT in Stable CAD in Modern Practice: Prevalence, Correlates, and Impact on Prognosis

Presenter: Gilles Lemesle

July 02, 2014

Presentation

Heparin Monotherapy or Bivalirudin During PCI in NSTE-ACS or Stable Ischemic Heart Disease

Presenter: Sripal Bangalore

April 22, 2014

Presentation PCI Outcomes 2014

Case Study 1: PCI vs. Optimal Medical Therapy in Stable CAD

Presenter: Sripal Bangalore

March 28, 2014

Presentation

Meta-analysis: PCI Outcomes in Patients with Stable Obstructive CAD and Myocardial Ischemia

Presenter: K. Stergiopoulos

December 05, 2013

Presentation

A Randomised Controlled Trial of Platelet Activity Before and After Cessation of Clopidogrel in Patients with Stable Cardiovascular Disease

Presenter: Isobel Ford

November 12, 2013

Presentation TCT 2013

Prasugrel for PCI in ACS and Stable CAD in Japan: PRASFIT-ACS and PRASFIT-Elective

Presenter: Masato Nakamura

October 31, 2013

Advertisement

Pro: Follow the Data - and Save the Money!

Definitely To Prevent Stent Thrombosis and MI!

Definitely Not An Expensive Way to Increase Bleeding Without Much Benefit!

The Case for Selective Use of Prasugrel and Ticagrelor in PCI Patients with Stable CAD

Time to Move to 3-6 Months Even in ACS!

Definitely Not the Data are Clear!

Definitely the Data are Clear!

The Data Strongly Support Heparin!

State of the (Drug-Eluting) Stent: World-Wide Usage, New Perspectives in Stable CAD, and Remaining Challenges

Position Statement: Heparin Will Once Again Become the Anticoagulant of Choice for PCI in Stable and Unstable Coronary Syndromes

Case #3. Multivessel Disease in a Stable CAD Patient

Impact of the System and Physician Factors on the Detection of Obstructive CAD with Diagnostic Angiography in Stable Ischemic Heart Disease

Prevalence of Anginal Symptoms and Myocardial Ischemia and Their Effect on Clinical Outcomes in Outpatients With Stable CAD

Rate of PCI for the Management of ACS and Stable CAD in the United States (2007-2011)

DAPT in Stable CAD in Modern Practice: Prevalence, Correlates, and Impact on Prognosis

Heparin Monotherapy or Bivalirudin During PCI in NSTE-ACS or Stable Ischemic Heart Disease

Case Study 1: PCI vs. Optimal Medical Therapy in Stable CAD

Meta-analysis: PCI Outcomes in Patients with Stable Obstructive CAD and Myocardial Ischemia

A Randomised Controlled Trial of Platelet Activity Before and After Cessation of Clopidogrel in Patients with Stable Cardiovascular Disease

Prasugrel for PCI in ACS and Stable CAD in Japan: PRASFIT-ACS and PRASFIT-Elective

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content